31 zoekresultaten voor “thrombosis” in de Publieke website
-
Borderline between cancer and thrombosis
Winning a prestigious award for PhD researchers, even before you have your doctorate: that's what Yascha van den Berg managed to do with his research proposal on alternatively spliced tissue factor, a protein that may be involved in tumour growth. Van den Berg: ‘It all started as a Friday afternoon…
-
Miranda van EckWiskunde en Natuurwetenschappen
-
Pieter ReitsmaFaculteit Geneeskunde
-
Deep Vein Thrombosis
Promotie
-
Genetic determinants of venous thrombosis
Promotie
-
Cardiometabolic risk factors and venous thrombosis
Promotie
-
Interplay between cancer and thrombosis; identification of key factors
Promotie
-
Risk factors of venous thrombosis in the elderly
Promotie
-
Novel Insights in Thrombosis Pathophysiology using Mice with Impaired Anticoagulation
Promotie
-
New insights in the risk profile for arterial thrombosis
Promotie
-
Risk Factors and Predictors for Recurrent Venous Thrombosis
Promotie
-
Risk factors for first and recurrent venous thrombosis
Promotie
-
Altered levels of coagulation factors in bleeding and thrombosis
Promotie
-
Modulation of leukocyte homeostasis in atherosclerosis
Promotores: Prof.dr. E.A.L. Biessen, Prof.dr. T.J.C. van Berkel
-
Conventional and age-specific risk factors for venous thrombosis in older people
Promotie
-
Thrombosis prophylaxis after knee arthroscopy or during lower leg cast immobilization
Promotie
-
solute carrier family 44 member 2 in the pathophysiology of venous thrombosis
Promotie
-
Prevention and prediction of venous thrombosis after knee arthroscopy or during plaster cast lower leg immobilization
Promotie
-
Aging and Immunity
The Aging and Immunity group is led by Dr. Amanda Foks. In this group we aim to investigate how aged immune cells contribute to atherosclerosis and identify novel therapeutic targets and strategies to extend health span and inhibit cardiovascular disease.
-
Making the most of the first time a medicine is administered to humans
Collecting as much information as possible about administering a new medicine to people can save a lot of money.
-
Cardiovascular and Metabolic Therapeutics
This research group, headed by Miranda van Eck, focusses on understanding the molecular mechanisms underlying cardiovascular and metabolic diseases. Cardiovascular disease constitutes a major health issue worldwide. Although significant knowledge has been obtained on the development of atherosclerotic…
-
Eight researchers to travel abroad on Rubicon grant
Eight young researchers from Leiden University have received a Rubicon grant from the Dutch Research Council (NWO). This will allow them to conduct research at a top institute or university abroad.
-
Research projects
The research of the Van Eck Group focusses on 3 interconnected research lines: 1) Identification and therapeutic targeting of key pathways/regulators in macrophages essential for prevention of atherosclerotic lesion development or stimulation of regression of existing lesions, 2) Atherosclerosis as…
-
Key publications
Selected publications of the Cardiovascular and Metabolic Therapeutics group.
-
Amanda Foks receives ERA-CVD consortium grant
Amanda Foks (Division of BioTherapeutics) has been awarded a Horizon 2020, ERA-CVD joint transnational cardiovascular research grant. She will lead a consortium consisting of early career European scientists (Dimitrios Tsiantoulas, Medical University of Vienna, Austria; Julia Polansky-Biskup, Charité…
-
Collaborative and effective drug development
There are many complex links in the chain that provides patients with new drugs: from fundamental science, to clinical tests, to production. The entire chain can be found in Leiden. Leiden University, the Leiden University Medical Center (LUMC) and the businesses at the Leiden Bio Science Park (LBSP)…
-
Nanoparticles can aid in stroke therapy
Tiny selenium particles could have a therapeutic effect on ischemic brain strokes by promoting the recovery of brain damage. Pharmacologists, including Alireza Mashaghi from the Leiden Academic Centre for Drug Research discovered that selenium nanoparticles inhibit molecular mechanisms that are responsible…
-
Developing a vaccine against arteriosclerosis
Cardiovascular diseases are the leading cause of death across the world. Professor Johan Kuiper of Leiden University carries out research to develop a vaccine for arteriosclerosis, which is the main cause of cardiovascular diseases. With the aid of a European research grant of six million euros he is…
-
Our Talents and Discoveries 2016
Christmas is coming, which means that 'Our Talents and Discoveries 2016' has been distributed. This also means that it is time to vote for the 'Discoverer of the year 2016'. Each of the eight institutes nominated one researcher that excelled in the past year. Who is your favourite?
-
2019 Hall of fame
Over the past year, many of our staff and students have won prizes, been awarded a substantial grant or been appointed to an academic association or a position in public life. All of these are good reasons to include them in our 2019 Hall of Fame. We are proud of them all.
-
Theses
Full texts of all bachelor, master and PhD theses are available on this site